5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A
View on ScienceDirect

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A

1st Edition - January 29, 2021

Write a review

  • Editors: Giuseppe Di Giovanni, Philippe De Deurwaerdère
  • Hardcover ISBN: 9780128245675
  • eBook ISBN: 9780128245682

Purchase options

Purchase options
Available
DRM-free (EPub, Mobi, PDF)
eBook Format Help
Sales tax will be calculated at check-out

Institutional Subscription

Support CenterReturns & Refunds
Free Global Shipping
No minimum order

Description

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Part B, Volume 260 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including  Serotonin-noradrenalin interactions, Electrophysiological and neurochemical evidence for an interaction of serotonin on noradrenergic neurons, Serotonin and cannabinoid system, 5-HT/CB interaction in the CNS in health and disease, Serotonin2A receptors and Cannabinoids, CB1/5-HT/GABA in food intake, A close interaction between serotonergic system and BDNF in the mechanism of action of antidepressant, 5-HT/ Ach, Interaction of 5-HT2A/2C ligands and nicotine, and more.

Key Features

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the Progress in Brain Research series
  • Includes the latest information on the 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance, Part B

Readership

Undergraduates, graduates, academics and researchers in the field of Progress in Brain Research

Table of Contents

  • Part 1: Serotonin-noradrenalin interactions
    1. Electrophysiological and neurochemical evidence for an interaction of serotonin on noradrenergic neurons
    Nasser Haddjeri

    Part 2: Serotonin and cannabinoid system
    2. 5-HT/CB interaction in the CNS in health and disease
    Roberto Colangeli
    3. Serotonin2A receptors and Cannabinoids
    Leyre Uriguen
    4. CB1/5-HT/GABA in food intake
    R. Erick Escartín-Pérez

    Part 3: Serotonin and and peptidergic systems
    5. A close interaction between serotonergic system and BDNF in the mechanism of action of antidepressant
    Bruno Guiard

    Part 4: 5-HT/ Ach
    6. Interaction of 5-HT2A/2C ligands and nicotine
    Guy Higgins

    Part 5: 5-HT/GABA
    7. 5-HT/GABA interaction in epilepsy
    Vincenzo Crunelli
    8. 5-HT/GABA interaction in neurodevelment and plasticity
    Gabriele Deidda

Product details

  • No. of pages: 332
  • Language: English
  • Copyright: © Elsevier 2021
  • Published: January 29, 2021
  • Imprint: Elsevier
  • Hardcover ISBN: 9780128245675
  • eBook ISBN: 9780128245682

About the Serial Volume Editors

Giuseppe Di Giovanni

Prof. Giuseppe Di Giovanni received his Ph.D. in Neuroscience from the University of Chieti, Italy and was a postdoctoral fellow at Yale University, USA. Previously Senior Lecturer of Human Physiology at the Faculty of Medicine and Surgery, University of Palermo, and Associate Professor at the University of Malta, from 2013 he is Professor of Human Physiology at the Medical School of the University of Malta and from 2018 Honorary Professor at Cardiff University, UK. His research focuses on understanding the pathophysiology of monoaminergic systems using electrophysiological and neurochemical approach. He has published more than 120 peer-reviewed papers, edited 7 books and 6 special issues of various journals.

Affiliations and Expertise

University of Malta, Malta

Philippe De Deurwaerdère

Professor Philippe De Deurwaerdère, Centre National de la Recherche Scientifique Bordeaux Cedex France

Affiliations and Expertise

Centre National de la Recherche Scientifique, France

Ratings and Reviews

Write a review

There are currently no reviews for "5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A"